Reply

Affiliations

¹ Department of Quality and Safety, Children's Hospital of Wisconsin, Milwaukee, Wisconsin.
² Department of Pediatrics, Children's Hospital of Wisconsin, Medical College of Wisconsin, Children's Research Institute, Milwaukee, Wisconsin.

Comment

Tracy N Zembles et al. J Pediatr. 2019 Sep.

. 2019 Sep:212:247-248.

doi: 10.1016/j.jpeds.2019.05.045. Epub 2019 Jun 14.

¹ Department of Quality and Safety, Children's Hospital of Wisconsin, Milwaukee, Wisconsin.
² Department of Pediatrics, Children's Hospital of Wisconsin, Medical College of Wisconsin, Children's Research Institute, Milwaukee, Wisconsin.

No abstract available

Comment on

Impact of American Academy of Pediatrics Palivizumab Guidance for Children ≥29 and <35 Weeks of Gestational Age.
Zembles TN, Bushee GM, Willoughby RE. Zembles TN, et al. J Pediatr. 2019 Jun;209:125-129. doi: 10.1016/j.jpeds.2019.02.020. Epub 2019 Apr 2. J Pediatr. 2019. PMID: 30952507
More on the impact of American Academy of Pediatrics palivizumab guidance for infants with respiratory syncytial virus infection.
Silvestri M, Sacco O, Rossi GA. Silvestri M, et al. J Pediatr. 2019 Sep;212:247. doi: 10.1016/j.jpeds.2019.05.044. Epub 2019 Jun 14. J Pediatr. 2019. PMID: 31204022 No abstract available.